FR2336413B1 - - Google Patents

Info

Publication number
FR2336413B1
FR2336413B1 FR7539275A FR7539275A FR2336413B1 FR 2336413 B1 FR2336413 B1 FR 2336413B1 FR 7539275 A FR7539275 A FR 7539275A FR 7539275 A FR7539275 A FR 7539275A FR 2336413 B1 FR2336413 B1 FR 2336413B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7539275A
Other languages
French (fr)
Other versions
FR2336413A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7539275A priority Critical patent/FR2336413A1/fr
Priority to DE19762658319 priority patent/DE2658319A1/de
Priority to GB5345176A priority patent/GB1554965A/en
Publication of FR2336413A1 publication Critical patent/FR2336413A1/fr
Application granted granted Critical
Publication of FR2336413B1 publication Critical patent/FR2336413B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7539275A 1975-12-22 1975-12-22 Nouveau procede de preparation du 3,17b-dihydroxy 7-oxo-estra 1,3,5(10)-triene Granted FR2336413A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR7539275A FR2336413A1 (fr) 1975-12-22 1975-12-22 Nouveau procede de preparation du 3,17b-dihydroxy 7-oxo-estra 1,3,5(10)-triene
DE19762658319 DE2658319A1 (de) 1975-12-22 1976-12-22 Neues verfahren zur herstellung von 3,17 beta-dihydroxy-7-oxo-oestra-1,3,5(10)- trien
GB5345176A GB1554965A (en) 1975-12-22 1976-12-22 Process for the preparation of 3,17 - dihydroxy - 7 - oxoestra - 1,3,5(10) - triene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7539275A FR2336413A1 (fr) 1975-12-22 1975-12-22 Nouveau procede de preparation du 3,17b-dihydroxy 7-oxo-estra 1,3,5(10)-triene

Publications (2)

Publication Number Publication Date
FR2336413A1 FR2336413A1 (fr) 1977-07-22
FR2336413B1 true FR2336413B1 (enrdf_load_stackoverflow) 1978-06-23

Family

ID=9164016

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7539275A Granted FR2336413A1 (fr) 1975-12-22 1975-12-22 Nouveau procede de preparation du 3,17b-dihydroxy 7-oxo-estra 1,3,5(10)-triene

Country Status (3)

Country Link
DE (1) DE2658319A1 (enrdf_load_stackoverflow)
FR (1) FR2336413A1 (enrdf_load_stackoverflow)
GB (1) GB1554965A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250874A1 (en) 1996-04-09 1997-10-16 Btg International Limited Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders

Also Published As

Publication number Publication date
FR2336413A1 (fr) 1977-07-22
DE2658319A1 (de) 1977-06-30
GB1554965A (en) 1979-10-31

Similar Documents

Publication Publication Date Title
FR2304450B1 (enrdf_load_stackoverflow)
FR2302280B1 (enrdf_load_stackoverflow)
FR2321966B3 (enrdf_load_stackoverflow)
JPS51121765U (enrdf_load_stackoverflow)
JPS5197740A (enrdf_load_stackoverflow)
FR2336413B1 (enrdf_load_stackoverflow)
FR2315944B1 (enrdf_load_stackoverflow)
JPS5241619U (enrdf_load_stackoverflow)
JPS51140756U (enrdf_load_stackoverflow)
JPS5618490Y2 (enrdf_load_stackoverflow)
JPS5241982U (enrdf_load_stackoverflow)
JPS5220023U (enrdf_load_stackoverflow)
JPS5210473U (enrdf_load_stackoverflow)
JPS51147396U (enrdf_load_stackoverflow)
JPS51122640U (enrdf_load_stackoverflow)
JPS51104196U (enrdf_load_stackoverflow)
CH603843A5 (enrdf_load_stackoverflow)
CH600489A5 (enrdf_load_stackoverflow)
DD118772A1 (enrdf_load_stackoverflow)
CH606525A5 (enrdf_load_stackoverflow)
CH606038A5 (enrdf_load_stackoverflow)
CH605381A5 (enrdf_load_stackoverflow)
CH604634A5 (enrdf_load_stackoverflow)
CH604019A5 (enrdf_load_stackoverflow)
CH600423B5 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
ST Notification of lapse